ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,332, issued on Oct. 27, was assigned to Genentech Inc. (South San Francisco, Calif.).
"Anti-CD8 antibodies and uses thereof" was invented by Yvonne M. Chen (San Mateo, Calif.), Eugene Yu-Chuan Chiang (Menlo Park, Calif.), Jane Louise Grogan (San Francisco), Simon-Peter Williams (Redwood City, Calif.) and Matthew Lawrence Albert (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are anti-CD8 antibodies that bind human CD8 and do not stimulate or inhibit the activation of CD8+ T cells. Also provided are nucleic acids encoding such anti-CD8 antibodies, vectors comprising such nucleic acids, host cells comprising same, and methods of...